Hebrew University of Jerusalem launched 15 spinouts last year covering areas ranging from healthcare to solar energy.
Yissum, the technology transfer arm of Hebrew University of Jerusalem, launched a total of 15 spinouts last year. The companies are: RNAWay, which has developed a platform for delivering siRNA to plants;Immunyx Pharma, which is working on technology for neutrophil specific targeting a mode of immunotherapy;Lipovac, which has set its sights on a liposome-based vaccine to…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
